-
1
-
-
77952889477
-
Ranibizumab for macular edema following central retinal vein occlusion: Six-month primary end point results of a phase III study
-
CRUISE Investigators
-
D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
-
(2010)
Ophthalmology
, vol.117
, pp. 1124-1133
-
-
Brown, D.M.1
Campochiaro, P.A.2
Singh, R.P.3
-
2
-
-
77952891051
-
Ranibizumab for macular edema following branch retinal vein occlusion: Six-month primary end point results of a phase III study
-
BRAVO Investigators
-
P.A. Campochiaro, J.S. Heier, L. Feiner BRAVO Investigators Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1102 1112
-
(2010)
Ophthalmology
, vol.117
, pp. 1102-1112
-
-
Campochiaro, P.A.1
Heier, J.S.2
Feiner, L.3
-
3
-
-
36749000600
-
Role of intravitreal bevacizumab in neovascular glaucoma
-
DOI 10.1089/jop.2007.0036
-
M.E. Gheith, G.A. Siam, and D.S. de Barros Role of intravitreal bevacizumab in neovascular glaucoma J Ocul Pharmacol Ther 23 2007 487 491 (Pubitemid 350202480)
-
(2007)
Journal of Ocular Pharmacology and Therapeutics
, vol.23
, Issue.5
, pp. 487-491
-
-
Gheith, M.E.1
Siam, G.A.2
Monteiro De Barros, D.S.3
Garg, S.J.4
Moster, M.R.5
-
4
-
-
77952779304
-
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
-
Diabetic Retinopathy Clinical Research Network
-
M.J. Elman, L.P. Aiello, R.W. Beck Diabetic Retinopathy Clinical Research Network Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 117 2010 1064 1077
-
(2010)
Ophthalmology
, vol.117
, pp. 1064-1077
-
-
Elman, M.J.1
Aiello, L.P.2
Beck, R.W.3
-
6
-
-
66049110107
-
Endophthalmitis after anti-VEGF injections [letter]
-
K.S. Klein, M.K. Walsh, and T.S. Hassan Endophthalmitis after anti-VEGF injections [letter] Ophthalmology 116 2009 1225
-
(2009)
Ophthalmology
, vol.116
, pp. 1225
-
-
Klein, K.S.1
Walsh, M.K.2
Hassan, T.S.3
-
7
-
-
66349109710
-
Infectious endophthalmitis after intravitreal injection of antiangiogenic agents
-
T. Diago, C.A. McCannel, and S.J. Bakri Infectious endophthalmitis after intravitreal injection of antiangiogenic agents Retina 29 2009 601 605
-
(2009)
Retina
, vol.29
, pp. 601-605
-
-
Diago, T.1
McCannel, C.A.2
Bakri, S.J.3
-
8
-
-
43049101583
-
Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting
-
S. Pilli, A. Kotsolis, and R.F. Spaide Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting Am J Ophthalmol 145 2008 879 882
-
(2008)
Am J Ophthalmol
, vol.145
, pp. 879-882
-
-
Pilli, S.1
Kotsolis, A.2
Spaide, R.F.3
-
9
-
-
76749090090
-
Toxic vitritis outbreak after intravitreal injection
-
T. Ness, N. Feltgen, and H. Agostini Toxic vitritis outbreak after intravitreal injection Retina 30 2010 332 338
-
(2010)
Retina
, vol.30
, pp. 332-338
-
-
Ness, T.1
Feltgen, N.2
Agostini, H.3
-
10
-
-
64849085452
-
Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)
-
M. Georgopoulos, K. Polak, and F. Prager Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin) Br J Ophthalmol 93 2009 457 462
-
(2009)
Br J Ophthalmol
, vol.93
, pp. 457-462
-
-
Georgopoulos, M.1
Polak, K.2
Prager, F.3
-
11
-
-
33749445317
-
Ranibizumab for neovascular age-related macular degeneration
-
DOI 10.1056/NEJMoa054481
-
P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431 (Pubitemid 44511557)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.14
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
Brown, D.M.2
Heier, J.S.3
Boyer, D.S.4
Kaiser, P.K.5
Chung, C.Y.6
Kim, R.Y.7
-
12
-
-
57949094834
-
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR Study
-
ANCHOR Study Group
-
D.M. Brown, M. Michels, P.K. Kaiser ANCHOR Study Group Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR Study Ophthalmology 116 2009 57 65
-
(2009)
Ophthalmology
, vol.116
, pp. 57-65
-
-
Brown, D.M.1
Michels, M.2
Kaiser, P.K.3
-
13
-
-
33749451356
-
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
-
DOI 10.1056/NEJMoa062655
-
D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444 (Pubitemid 44511558)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.14
, pp. 1432-1444
-
-
Brown, D.M.1
Kaiser, P.K.2
Michels, M.3
Soubrane, G.4
Heier, J.S.5
Kim, R.Y.6
Sy, J.P.7
Schneider, S.8
-
14
-
-
58949083350
-
Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab
-
D.R. Fintak, G.K. Shah, and K.J. Blinder Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab Retina 28 2008 1395 1399
-
(2008)
Retina
, vol.28
, pp. 1395-1399
-
-
Fintak, D.R.1
Shah, G.K.2
Blinder, K.J.3
-
15
-
-
75149116508
-
Intravitreal bevacizumab and ranibizumab for age-related macular degeneration: A multicenter, retrospective study
-
D.S. Fong, P. Custis, J. Howes, and J.W. Hsu Intravitreal bevacizumab and ranibizumab for age-related macular degeneration: a multicenter, retrospective study Ophthalmology 117 2010 298 302
-
(2010)
Ophthalmology
, vol.117
, pp. 298-302
-
-
Fong, D.S.1
Custis, P.2
Howes, J.3
Hsu, J.W.4
-
16
-
-
77949369713
-
Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch
-
K. Yamashiro, A. Tsujikawa, and K. Miyamoto Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch Retina 30 2010 485 490
-
(2010)
Retina
, vol.30
, pp. 485-490
-
-
Yamashiro, K.1
Tsujikawa, A.2
Miyamoto, K.3
-
17
-
-
54949136462
-
Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration
-
S.S. Wickremasinghe, K. Michalova, and J. Gilhotra Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration Ophthalmology 115 2008 1911 1915
-
(2008)
Ophthalmology
, vol.115
, pp. 1911-1915
-
-
Wickremasinghe, S.S.1
Michalova, K.2
Gilhotra, J.3
-
18
-
-
77954697544
-
Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor
-
D. Mezad-Koursh, M. Goldstein, and G. Heilwail Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor Retina 30 2010 1051 1057
-
(2010)
Retina
, vol.30
, pp. 1051-1057
-
-
Mezad-Koursh, D.1
Goldstein, M.2
Heilwail, G.3
-
19
-
-
42549140659
-
Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection
-
DOI 10.1097/IAE.0b013e3181633fee, PII 0000698220080400000006
-
J.O. Mason III, M.F. White, and R.M. Feist Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection Retina 28 2008 564 567 (Pubitemid 351589565)
-
(2008)
Retina
, vol.28
, Issue.4
, pp. 564-567
-
-
Mason III, J.O.1
White, M.F.2
Feist, R.M.3
Thomley, M.L.4
Albert, M.A.5
Persaud, T.O.6
Yunker, J.J.7
Vail, R.S.8
-
20
-
-
0026344747
-
Prophylaxis of endophthalmitis with topical povidone-iodine
-
M.G. Speaker, and J.A. Menikoff Prophylaxis of endophthalmitis with topical povidone-iodine Ophthalmology 98 1991 1769 1775
-
(1991)
Ophthalmology
, vol.98
, pp. 1769-1775
-
-
Speaker, M.G.1
Menikoff, J.A.2
-
21
-
-
67949109540
-
A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections
-
J.M. Moss, S.R. Sanislo, and C.N. Ta A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections Ophthalmology 116 2009 1498 1501
-
(2009)
Ophthalmology
, vol.116
, pp. 1498-1501
-
-
Moss, J.M.1
Sanislo, S.R.2
Ta, C.N.3
-
22
-
-
52049105631
-
Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival
-
J.H. Boden, M.L. Myers, and T. Lee Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival J Cataract Refract Surg 34 2008 1773 1775
-
(2008)
J Cataract Refract Surg
, vol.34
, pp. 1773-1775
-
-
Boden, J.H.1
Myers, M.L.2
Lee, T.3
-
23
-
-
77951545882
-
Preoperative lidocaine gel [letter]
-
author reply 1049
-
S. Awotesu, and T. Eke Preoperative lidocaine gel [letter] Ophthalmology 117 2010 1049 author reply 1049
-
(2010)
Ophthalmology
, vol.117
, pp. 1049
-
-
Awotesu, S.1
Eke, T.2
-
24
-
-
33646948521
-
Pegaptanib sodium for neovascular age-related macular degeneration: Two-year safety results of the two prospective, multicenter, controlled clinical trials
-
VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group
-
VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials Ophthalmology 113 2006 992 1001
-
(2006)
Ophthalmology
, vol.113
, pp. 992-1001
-
-
-
25
-
-
6344251620
-
Minimizing the risk of endophthalmitis following intravitreous injections
-
DOI 10.1097/00006982-200410000-00003
-
C.N. Ta Minimizing the risk of endophthalmitis following intravitreous injections Retina 24 2004 699 705 (Pubitemid 39391759)
-
(2004)
Retina
, vol.24
, Issue.5
, pp. 699-705
-
-
Ta, C.N.1
-
26
-
-
33846244134
-
Reducing the risk of endophthalmitis following intravitreal injections
-
DOI 10.1097/IAE.0b013e3180307271, PII 0000698220070100000003
-
I.U. Scott, and H.W. Flynn Jr Reducing the risk of endophthalmitis following intravitreal injections Retina 27 2007 10 12 (Pubitemid 46095824)
-
(2007)
Retina
, vol.27
, Issue.1
, pp. 10-12
-
-
Scott, I.U.1
Flynn Jr., H.W.2
-
27
-
-
73349107165
-
Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: The Diabetic Retinopathy Clinical Research Network laser-ranibizumab-triamcinolone clinical trials
-
Diabetic Retinopathy Clinical Research Network
-
A.R. Bhavsar, J.M. Googe Jr, C.R. Stockdale Diabetic Retinopathy Clinical Research Network Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the Diabetic Retinopathy Clinical Research Network laser-ranibizumab-triamcinolone clinical trials Arch Ophthalmol 127 2009 1581 1583
-
(2009)
Arch Ophthalmol
, vol.127
, pp. 1581-1583
-
-
Bhavsar, A.R.1
Googe, Jr.J.M.2
Stockdale, C.R.3
-
28
-
-
6344263392
-
Evolving guidelines for intravitreous injections
-
L.P. Aiello, A.J. Brucker, and S. Chang Evolving guidelines for intravitreous injections Retina 24 suppl 2004 S3 S19
-
(2004)
Retina
, vol.24
, Issue.SUPPL.
-
-
Aiello, L.P.1
Brucker, A.J.2
Chang, S.3
-
29
-
-
0029914957
-
Bleb-related endophthalmitis after trabeculectomy with mitomycin C
-
E.J. Higginbotham, R.K. Stevens, and D.C. Musch Bleb-related endophthalmitis after trabeculectomy with mitomycin C Ophthalmology 103 1996 650 656 (Pubitemid 26114237)
-
(1996)
Ophthalmology
, vol.103
, Issue.4
, pp. 650-656
-
-
Higginbotham, E.J.1
Stevens, R.K.2
Musch, D.C.3
Karp, K.O.4
Lichter, P.R.5
Bergstrom, T.J.6
Skuta, G.L.7
-
30
-
-
0037564127
-
Glaucoma-filtering bleb infections
-
DOI 10.1097/00055735-200304000-00007
-
I. Mac, and J.B. Soltau Glaucoma-filtering bleb infections Curr Opin Ophthalmol 14 2003 91 94 (Pubitemid 36584228)
-
(2003)
Current Opinion in Ophthalmology
, vol.14
, Issue.2
, pp. 91-94
-
-
Mac, I.1
Soltau, J.B.2
-
31
-
-
0001099413
-
Value of cultures before operation for cataract
-
J.H. Dunnington, and D. Locatcher-Khorazo Value of cultures before operation for cataract Arch Ophthal 34 1945 215 219
-
(1945)
Arch Ophthal
, vol.34
, pp. 215-219
-
-
Dunnington, J.H.1
Locatcher-Khorazo, D.2
-
32
-
-
26844543549
-
Re: Evolving guidelines for intravitreous injections [letter]
-
author reply 950
-
S.J. Garg, and F.M. Recchia Re: Evolving guidelines for intravitreous injections [letter] Retina 25 2005 949 950 author reply 950
-
(2005)
Retina
, vol.25
, pp. 949-950
-
-
Garg, S.J.1
Recchia, F.M.2
-
33
-
-
0028839594
-
Results of the Endophthalmitis Vitrectomy Study: A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis
-
Endophthalmitis Vitrectomy Study Group
-
Endophthalmitis Vitrectomy Study Group Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis Arch Ophthalmol 113 1995 1479 1496
-
(1995)
Arch Ophthalmol
, vol.113
, pp. 1479-1496
-
-
-
34
-
-
0030885287
-
Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study
-
M. Barza, P.R. Pavan, B.H. Doft Endophthalmitis Vitrectomy Study Group Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study Arch Ophthalmol 115 1997 1142 1150 (Pubitemid 27387950)
-
(1997)
Archives of Ophthalmology
, vol.115
, Issue.9
, pp. 1142-1150
-
-
Barza, M.1
Pavan, P.R.2
Doft, B.H.3
Wisniewsfci, S.R.4
Wilson, L.A.5
Han, D.P.6
Kehey, S.F.7
-
35
-
-
42049115622
-
Intraocular inflammation following intravitreal injection of bevacizumab
-
S.J. Bakri, T.A. Larson, and A.O. Edwards Intraocular inflammation following intravitreal injection of bevacizumab Graefes Arch Clin Exp Ophthalmol 246 2008 779 781
-
(2008)
Graefes Arch Clin Exp Ophthalmol
, vol.246
, pp. 779-781
-
-
Bakri, S.J.1
Larson, T.A.2
Edwards, A.O.3
|